Christel Menet

1.7k total citations
27 papers, 1.3k citations indexed

About

Christel Menet is a scholar working on Organic Chemistry, Molecular Biology and Oncology. According to data from OpenAlex, Christel Menet has authored 27 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Organic Chemistry, 9 papers in Molecular Biology and 7 papers in Oncology. Recurrent topics in Christel Menet's work include Coordination Chemistry and Organometallics (8 papers), Asymmetric Synthesis and Catalysis (6 papers) and Cytokine Signaling Pathways and Interactions (6 papers). Christel Menet is often cited by papers focused on Coordination Chemistry and Organometallics (8 papers), Asymmetric Synthesis and Catalysis (6 papers) and Cytokine Signaling Pathways and Interactions (6 papers). Christel Menet collaborates with scholars based in Belgium, United Kingdom and France. Christel Menet's co-authors include Philippe Soubrié, M. Arnone, Jonathan Clayden, Raphaël Geney, Luc Van Rompaey, Darren J. Mansfield, Philippe Clément-Lacroix, Reginald Brys, Thierry Christophe and Kirill Tchabanenko and has published in prestigious journals such as Journal of the American Chemical Society, Angewandte Chemie International Edition and The Journal of Immunology.

In The Last Decade

Christel Menet

27 papers receiving 1.3k citations

Peers

Countries citing papers authored by Christel Menet

Since Specialization

Citations

This map shows the geographic impact of Christel Menet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christel Menet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christel Menet more than expected).

Fields of papers citing papers by Christel Menet

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christel Menet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christel Menet. The network helps show where Christel Menet may publish in the future.

Co-authorship network of co-authors of Christel Menet

This figure shows the co-authorship network connecting the top 25 collaborators of Christel Menet. A scholar is included among the top collaborators of Christel Menet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christel Menet. Christel Menet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Accelerating GPCR Drug Discovery With Conformation-Stabilizing VHHs 2022 ·Frontiers in Molecular Biosciences ·Toon Laeremans, Zara A. Sands, (unknown), (unknown), Stéphane De Cesco, Sarah Triest, Andreas Büsch, David H Felix, (unknown), Veli‐Pekka Jaakola, Christel Menet	26
2	Modulation of sleep behavior in zebrafish larvae by pharmacological targeting of the orexin receptor 2022 ·Frontiers in Pharmacology ·(unknown), (unknown), (unknown), (unknown), Aleksandra Siekierska, Christel Menet, Peter de Witte, Daniëlle Copmans	4
3	Discovery of GLPG2451, a Novel Once Daily Potentiator for the Treatment of Cystic Fibrosis 2021 ·Journal of Medicinal Chemistry ·(unknown), (unknown), (unknown), Christel Menet, (unknown), (unknown), Caroline Joannesse, (unknown), (unknown), Marlon Cowart, (unknown), (unknown), Maarten Gees, (unknown), Katja Conrath, Martin Andrews	17
4	Wandering beyond small molecules: peptides as allosteric protein modulators 2021 ·Trends in Pharmacological Sciences ·(unknown), Charlotte Martin, Christel Menet, Steven Ballet	23
5	Development of Generic G Protein Peptidomimetics Able to Stabilize Active State G_s Protein‐Coupled Receptors for Application in Drug Discovery 2021 ·Angewandte Chemie International Edition ·(unknown), Charlotte Martin, Sarah Triest, Marilisa Pia Dimmito, Adriano Mollica, Toon Laeremans, Christel Menet, Steven Ballet	11
6	Discovery of the S1P2 Antagonist GLPG2938 (1-[2-Ethoxy-6-(trifluoromethyl)-4-pyridyl]-3-[[5-methyl-6-[1-methyl-3-(trifluoromethyl)pyrazol-4-yl]pyridazin-3-yl]methyl]urea), a Preclinical Candidate for the Treatment of Idiopathic Pulmonary Fibrosis 2021 ·Journal of Medicinal Chemistry ·(unknown), (unknown), Caroline Joannesse, (unknown), (unknown), (unknown), Christel Menet, (unknown), (unknown), (unknown), Philippe Clément-Lacroix, Line Oste, Monica Borgonovi, Emanuelle Wakselman, Thierry Christophe, (unknown), (unknown), Bertrand Heckmann, Laurent Sanière, Reginald Brys	18
7	Regio‐ and Diastereoselective Functionalization of 3‐Amino‐hexahydrooxazoninones 2018 ·European Journal of Organic Chemistry ·(unknown), Johan Wouters, (unknown), Guy Van Lommen, Christel Menet, Guido Verniest	3
8	A Dual Inhibition, a Better Solution: Development of a JAK1/TYK2 inhibitor 2018 ·Journal of Medicinal Chemistry ·Christel Menet	13
9	Progress Toward JAK1-Selective Inhibitors 2015 ·Future Medicinal Chemistry ·Christel Menet, (unknown), (unknown)	15
10	Advances in the Discovery of Selective JAK Inhibitors 2013 ·Progress in medicinal chemistry ·Christel Menet, Luc Van Rompaey, Raphaël Geney	61
11	Type II Kinase Inhibitors: An Opportunity in Cancer for Rational Design 2013 ·Anti-Cancer Agents in Medicinal Chemistry ·(unknown), Raphaël Geney, Christel Menet	74
12	Preclinical Characterization of GLPG0634, a Selective Inhibitor of JAK1, for the Treatment of Inflammatory Diseases 2013 ·The Journal of Immunology ·Luc Van Rompaey, René Galien, Ellen M. van der Aar, Philippe Clément-Lacroix, L Nelles, Bart Smets, L. Lepescheux, Thierry Christophe, Katja Conrath, N. Vandeghinste, Béatrice Vayssière, Steve De Vos, Stephen R. Fletcher, Reginald Brys, Gerben van ‘t Klooster, Jean H.M. Feyen, Christel Menet	181
13	Design and synthesis of APTCs (aminopyrrolidinetricarboxylic acids): Identification of a new group III metabotropic glutamate receptor selective agonist 2006 ·Bioorganic & Medicinal Chemistry Letters ·Stéphan Schann, Christel Menet, (unknown), (unknown), (unknown), Stanislas Mayer, Nadia Hubert, Nicolas Triballeau, Hugues‐Olivier Bertrand, Francine Acher, Pascal Neuville	10
14	Expediting drug discovery: recent advances in fast medicinal chemistry--optimization of hits and leads. 2006 ·PubMed ·(unknown), (unknown), (unknown), (unknown), Christel Menet	7
15	CB1 cannabinoid receptor knockout in mice leads to leanness, resistance to diet-induced obesity and enhanced leptin sensitivity 2004 ·International Journal of Obesity ·(unknown), (unknown), Christel Menet, M. Arnone, Philippe Soubrié	475
16	Synthesis of α-methyl kainic acid by stereospecific lithiation–dearomatizing cyclization of a chiral benzamide 2003 ·Tetrahedron Letters ·Jonathan Clayden, (unknown), Christel Menet	25
17	Stereospecific DearomatisingCyclisation of Tertiary α-Amidoorganolithiums 2003 ·Synlett ·Jonathan Clayden, (unknown), Christel Menet	19
18	Stereospecific Photochemical Ring Expansion of Lithiated Benzamides 2003 ·Journal of the American Chemical Society ·Jonathan Clayden, (unknown), Christel Menet	25
19	‘meso-Selective’ functionalisation of N-benzyl-α-methylbenzylamine derivatives by α-lithiation and alkylation 2002 ·Tetrahedron Letters ·Ryan A. Bragg, Jonathan Clayden, Christel Menet	8
20	Asymmetric deprotonation and dearomatising cyclisation of N-benzyl benzamides using chiral lithium amides: formal synthesis of (–)-kainic acid 2001 ·Chemical Communications ·Jonathan Clayden, Christel Menet, Darren J. Mansfield	43

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact